Dr. Gail Galasko

Dr. Gail Galasko earned her Ph.D from Queen Mary College University of London. Research in the Galasko Lab is focused on understanding the mechanism of action of insulin and what causes the insulin resistance found in type 2 diabetes mellitus. They have isolated 2 small compounds which act as second messengers in the insulin signaling pathway, and a third which inhibits insulin action. Her hypothesis that these compounds have an important physiological role in the maintenance of normal blood sugar, and that lack of the insulin second messengers is an important factor in diabetes and its complications. She believes that findings from her studies will have important implications in understanding of and developing new treatments for diabetes.